Hongliang Li

发表

Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy

Jingjing Cai, Zhibing Lu, Fang Lei, 2022, Journal of Molecular Medicine.

The increasing incidence and high body mass index-related burden of gallbladder and biliary diseases–A results from global burden of disease study 2019

P. Zhang, Fang Lei, J. Qin, 2022, Frontiers in Medicine.

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction

Zhi‐Gang She, Xiao-Jing Zhang, Rui-Feng Tian, 2023, Frontiers in Cardiovascular Medicine.

Impact of NAFLD and its pharmacotherapy on lipid profile and CVD.

Jingjing Cai, P. Zhang, Zhi‐Gang She, 2022, Atherosclerosis.

The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19

Yibin Wang, X. Liao, J. Xia, 2021, Cell Metabolism.

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Fang Lei, Jiao Guo, Peng Zhang, 2020, Cell Metabolism.

Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.

X. Liao, Yibin Wang, Hongliang Li, 2020, Hypertension.

Nonalcoholic Fatty Liver Disease

Hongliang Li, Jingjing Cai, Zhibing Lu, 2021, Circulation research.

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

Zhi‐Gang She, Fang Lei, Xuewei Huang, 2023, Frontiers in Endocrinology.

The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China

P. Zhang, J. Xia, Zhi‐Gang She, 2022, Frontiers in Endocrinology.

Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease.

Jingjing Cai, Zhi‐Gang She, Feng Zhou, 2021, Cell metabolism.

Recent updates on targeting the molecular mediators of NAFLD

P. Zhang, Zhi‐Gang She, Xiao-Jing Zhang, 2023, Journal of Molecular Medicine.

The projections of global and regional rheumatic heart disease burden from 2020 to 2030

Zhi‐Gang She, Fang Lei, J. Qin, 2022, Frontiers in Cardiovascular Medicine.

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

P. Ye, Jing Xie, J. Chen, 2020, Hepatology.

Extracorporeal Membrane Oxygenation Therapy for Critically Ill Coronavirus Disease 2019 Patients in Wuhan, China: A Retrospective Multicenter Cohort Study

Bo Yang, J. Xia, Fei Huang, 2020, Current Medical Science.

Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: Results from the Global Burden of Disease study 2019.

P. Zhang, Zhi‐Gang She, Ye Liu, 2022, Atherosclerosis.

Heavy Disease Burden of High Systolic Blood Pressure During 1990-2019: Highlighting Regional, Sex, and Age Specific Strategies in Blood Pressure Control

Hongliang Li, Jingjing Cai, Zhibing Lu, 2021, Frontiers in Cardiovascular Medicine.

Long-term exposure to air pollution and increased risk of atrial fibrillation prevalence in China.

P. Zhang, Zhi‐Gang She, Fang Lei, 2023, International journal of cardiology.

The Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Peripheral Arterial Disease in the Chinese Population

P. Zhang, Zhi‐Gang She, Ye Liu, 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.

No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19

Hao Li, Jingjing Cai, Jianghua Zhou, 2020, World journal of clinical cases.

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

P. Ye, Yibin Wang, Jingjing Cai, 2020, Cell Metabolism.

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome

Z. Cai, Zhi‐Gang She, Xiao-Jing Zhang, 2023, Chinese Medicine.

Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data

Jingjing Cai, P. Zhang, Zhi‐Gang She, 2022, Respiratory Research.

Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population.

P. Zhang, Zhibing Lu, Zhi‐Gang She, 2023, Atherosclerosis.

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China

P. Zhang, Zhi‐Gang She, Ye Liu, 2023, Frontiers in Endocrinology.

Association between Lipid Profiles and Left Ventricular Hypertrophy: New Evidence from a Retrospective Study.

Jingjing Cai, Zhi‐Gang She, Fang Lei, 2022, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China

Shujuan Yang, P. Zhang, Zhi‐Gang She, 2023, Journal of atherosclerosis and thrombosis.

The Transition of Cardiovascular Disease Risks from NAFLD to MAFLD

P. Zhang, Zhi‐Gang She, Xiao-Jing Zhang, 2023, Reviews in Cardiovascular Medicine.

Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease.

Jingjing Cai, P. Zhang, Zhi‐Gang She, 2022, American journal of physiology. Cell physiology.

Kidney Function Indicators Predict Adverse Outcomes of COVID-19

Yibin Wang, Hongliang Li, Jingjing Cai, 2020, Med.

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure

Zhi‐Gang She, Xu Cheng, Xiao-Jing Zhang, 2023, Frontiers in Cardiovascular Medicine.

The rising death burden of atrial fibrillation and flutter in low-income regions and younger populations

P. Zhang, Zhi‐Gang She, Ye Liu, 2023, Frontiers in Epidemiology.

Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012–2017

P. Zhang, Zhi‐Gang She, Ye Liu, 2023, Frontiers in Cardiovascular Medicine.

The association of apolipoprotein B with chronic kidney disease in the Chinese population

Q. Zeng, Fang Lei, Xiaohui Song, 2023, Frontiers in Endocrinology.

Reply to Letter to the Editor: COVID-19-Related Liver Injury and Clinical Outcomes: Does It Really Exist?

Yufeng Yuan, Feng Zhou, Ye Liu, 2020, Hepatology.

Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank

Zhi‐Gang She, Xiao-Jing Zhang, Xuewei Huang, 2024, Cardiovascular diabetology.